SEC Filing Details

Detailed Financial Reporting & Filings

Access Aprea Therapeutics’ quarterly and annual reports, earnings disclosures, and SEC filings. These financial documents reflect our commitment to transparency, regulatory compliance, and delivering clear insight into our operational and fiscal performance.

Document Details

Filing Date
Nov 18, 2020
Document Date
Nov 18, 2020
Form Description
UPLOAD
Filing Group
Other
Company
Aprea Therapeutics
Issuer
Aprea Therapeutics, Inc.